Identifying the major targets of protective antibodies against malaria

确定抗疟疾保护性抗体的主要靶标

• 批准号: FT0992317
• 负责人: Prof James Beeson
• 金额: $ 48.96万
• 依托单位: Macfarlane Burnet Institute for Medical Research and Public Health Ltd.
• 依托单位国家: 澳大利亚
• 项目类别: ARC Future Fellowships
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/FT0992317
• 关键词: Identifying; major; targets; protective; antibodies

This project aims to understand how immunity to malaria develops and to use this knowledge to develop effective vaccines against malaria. The development of a malaria vaccine would be of great value in Australia's region where malaria is a leading cause of death and illness and impairs economic development. The project will advance our knowledge of how the immune system fights infections and will contribute to building Australia's strength in infectious diseases research and developing strategies to combat important infections. The project will help build and maintain expertise in developing vaccines in Australia and the approaches used and knowledge gained will be applicable to understanding and combating other important infections.

该项目旨在了解疟疾免疫力是如何发展的，并利用这些知识开发有效的疟疾疫苗。疟疾疫苗的研制将对澳大利亚区域具有重大价值，因为疟疾是该区域死亡和疾病的主要原因，并损害经济发展。该项目将提高我们对免疫系统如何对抗感染的认识，并将有助于建立澳大利亚在传染病研究和制定战略以对抗重要感染方面的实力。该项目将帮助澳大利亚建立和保持疫苗开发方面的专门知识，所采用的方法和获得的知识将适用于了解和防治其他重要的感染。